2016
DOI: 10.1093/bjaed/mkv051
|View full text |Cite
|
Sign up to set email alerts
|

Paediatric massive transfusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

2
11
0
3

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 11 publications
2
11
0
3
Order By: Relevance
“…Pediatric population is especially vulnerable to massive bleeding due to an immature hemostatic mechanism such as low coagulant and procoagulant concentration as well as relatively dysfunctional fibrinogen. 10 This study demonstrated that massive bleeding occurred in 31 out of 34 cases (91%).…”
Section: Discussionmentioning
confidence: 69%
See 1 more Smart Citation
“…Pediatric population is especially vulnerable to massive bleeding due to an immature hemostatic mechanism such as low coagulant and procoagulant concentration as well as relatively dysfunctional fibrinogen. 10 This study demonstrated that massive bleeding occurred in 31 out of 34 cases (91%).…”
Section: Discussionmentioning
confidence: 69%
“…For this reason, signs and symptoms of hypovolemia cannot be used as a predictor of early blood loss. 10 Nacoti, et al reported that bleeding volume and allogeneic red cell transfusion affected patient and transplant outcome. 12 It is also interesting to note that there was a discrepancy in the bleeding volume and the transfused PRC volume reported in this study.…”
Section: Discussionmentioning
confidence: 99%
“…Hypocalcaemia and hypokalaemia were observed after transfusion of two units of pRBC and one unit of FFP alongside the administration of Hartmann's solution and gelatin based colloids. This can be caused by dilutional effects, citrate overload, hypoproteinemia and re-entry of electrolytes into transfused cells (Blain and Paterson, 2016). There were no changes on the electrocardiogram, such as a prolonged QT interval or inversion of the T wave (Chodan and Davidow, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…Tranexamic acid (TA) is an antifibrinolytic drug. In people there is evidence that when administered during active bleeding it reduces blood loss and requirements for blood transfusion (Blain and Paterson, 2016). Tranexamic acid has been evaluated in healthy dogs and has been reported to be safe at clinical doses of 10 mg/kg (Kelmer et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation